PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC)- THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.980
https://www.valueinhealthjournal.com/article/S1098-3015(11)01119-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
458
First Page :
A177
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01119-3&doi=10.1016/j.jval.2011.02.980